Sequence analyses of human tumor-associated SV40 DNAs and SV40 viral isolates from monkeys and humans

Journal of NeuroVirology

Volumn 4, Issue 2, 1998, Pages 182-193

  Stewart, A Renee ^a   Lednicky, John A ^a   Butel, Janet S ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Genome sequences; Human tumors; Polyomavirus; Regulatory region; SV40; T antigen; Viral isolates

Indexed keywords

VIRUS DNA; VIRUS LARGE T ANTIGEN;

ARTICLE; BRAIN TUMOR; CARBOXY TERMINAL SEQUENCE; DNA SEQUENCE; HUMAN; MONKEY; NONHUMAN; OSTEOSARCOMA; PRIORITY JOURNAL; REGULATOR GENE; SEQUENCE HOMOLOGY; SIMIAN VIRUS 40; VIRUS CARCINOGENESIS;

EID: 0031971856     PISSN: 13550284     EISSN: None     Source Type: Journal    
DOI: 10.3109/13550289809114518     Document Type: Article

References (53)

1. Barkan A, Mertz JE (1981). DNA sequence analysis of simian virus 40 mutants with deletions mapping in the leader region of the late mRNAs: mutants with deletions similar in size and position exhibit varied phenotypes. J Virol 37: 730-737.
2. Bergsagel DJ, Finegold MJ, Butel JS, Kupsky WJ, Garcea RL (1992). DNA sequences similar to those of simian virus 40 in ependymomas and choroid plexus tumors of childhood. New Engl J Med 326: 988-993.
3. Buckler CE, Salzman NP (1986). Annotated nucleotide sequence and restriction site lists for selected papovavirus strains. In: The Papovaviridae. Volume 1: The Polyomaviruses. Salzman NP (ed). Plenum Press: New York, pp 379-387.
4. Butel JS (1994). Simian virus 40. In: Encyclopedia of Virology. Webster RG, Granoff A (eds). Academic Press: San Diego, vol 3, pp 1322-1329.
5. Carbone M, Pass HI, Rizzo P, Marinetti MR, Di Muzio M, Mew DJY, Levine AS, Procopio A (1994). Simian virus 40-like DNA sequences in human pleural mesothelioma. Oncogene 9: 1781-1790.
6. Carbone M, Rizzo P, Procopio A, Giuliano M, Pass HI, Gebhardt MC, Mangham C, Hansen M, Malkin DF, Bushart G, Pompetti F, Picci P, Levine AS, Bergsagel JD, Garcea RL (1996). SV40-like sequences in human bone tumors. Oncogene 13: 527-535.
7. Chang D, Liou ZM, Ou WC, Wang KZ, Wang M, Fung CY, Tsai RT (1996). Production of the antigen and the antibody of the JC virus major capsid protein VP1. J Virol Meth 59: 177-187.
8. Cole CN (1996). Polyomavirinae: the viruses and their replication. In: Fields Virology, 3rd ed. Fields BN et al (eds). Lippincott-Raven: Philadelphia, pp 1997-2025.
9. Cristaudo A, Vivaldi A, Sensales G, Guglielmi G, Cianca E, Elisei R, Ottenga F (1995). Molecular biology studies on mesothelioma tumor samples: preliminary data on H-Ras, p21 and SV40. J Environ Pathol Toxicol Oncol 14: 29-34.
10. Eddy BE, Borman GS, Berkeley WH, Young RD (1961). Tumors induced in hamsters by injection of rhesus monkey kidney cell extracts. Proc Soc Exp Biol Med 107: 191-197.
11. Eddy BE, Borman GS, Grubbs GE, Young RD (1962). Identification of the oncogenic substance in rhesus monkey kidney cell cultures as simian virus 40. Virology 17: 65-75.
12. Fanning E (1992). Simian virus 40 large T antigen: the puzzle, the pieces, and the emerging picture. J Virol 66: 1289-1293.
13. Fiers W, Contreras R, Haegeman G, Rogiers R, Van de Voorde A, Van Heuverswyn H, Van Herreweghe J, Volckaert G, Ysebaert M (1978). Complete nucleotide sequence of SV40 DNA. Nature 273: 113-120.
14. Frisque RJ (1994). JC and BK viruses. In: Encyclopedia of Virology. Webster RG, Granoff A (eds). Academic Press: San Diego, vol 2, pp 752-757.
15. Geissler E (1990). SV40 and human brain tumors. Prog Med Virol 37: 211-222.
16. Geissler E, Konzer P, Scherneck S, Zimmermann W (1985). Sera collected before introduction of contaminated polio vaccine contain antibodies against SV40. Acta Virol 29: 420-423.
17. Girardi AJ (1965). Prevention of SV40 virus oncogenesis in hamsters, I. Tumor resistance induced by human cells transformed by SV40. Proc Natl Acad Sci USA 54: 445-451.
18. Girardi AJ, Sweet BH, Slotnick VB, Hilleman MR (1962). Development of tumors in hamsters inoculated in the neonatal period with vacuolating virus, SV40. Proc Soc Exp Biol Med 109: 649-660.
19. Hampil B (1973). Personal communication.
20. Hsiung GD, Gaylord WH Jr (1961). The vacuolating virus of monkeys. I. Isolation, growth characteristics, and inclusion body formation. J Exp Med 114: 975-985.
21. Ilyinskii PO, Daniel MD, Horvath CJ, Desrosiers RC (1992). Genetic analysis of simian virus 40 from brains and kidneys of macaque monkeys. J Virol 66: 6353-6360.
22. Jay G, Nomura S, Anderson CW, Khoury G (1981). Identification of the SV40 agnogene product: a DNA binding protein. Nature 291: 346-349.
23. Krieg P, Amtmann E, Jonas D, Fischer H, Zang K, Sauer G (1981). Episomal simian virus 40 genomes in human brain tumors. Proc Natl Acad Sci USA 78: 6446-6450.
24. Krieg P, Scherer G (1984). Cloning of SV40 genomes from human brain tumors. Virology 138: 336-340.
25. Lednicky JA, Butel JS (1997). Tissue culture adaptation of natural isolates of simian virus 40: changes occur in viral regulatory region but not in carboxy-terminal domain of large T-antigen. J Gen Virol 78: 1697-1705.
26. Lednicky JA, Garcea RL, Bergsagel DJ, Butel JS (1995a). Natural simian virus 40 strains are present in human choroid plexus and ependymoma tumors. Virology 212: 710-717.
27. Lednicky JA, Stewart AR, Jenkins JJ III, Finegold MJ, Butel JS (1997). SV40 DNA in human osteosarcomas shows sequence variation among T-antigen genes. Int J Cancer, 72: 791-800.
28. Lednicky JA, Wong C, Butel JS (1995b). Artificial modification of the viral regulatory region improves tissue culture growth of SV40 strain 776. Virus Res 35: 143-153.
29. Liddington RC, Yan Y, Moulai J, Sahli R, Benjamin TL, Harrison SC (1991). Structure of simian virus 40 at 3.8 Å resolution. Nature 354: 278-284.
30. Martin JD (1989). Regulatory sequences of SV40 variants isolated from patients with progressive multifocal leukoencephalopathy. Virus Res 14: 85-94.
31. Martin JD, Li P (1991). Comparison of regulatory sequences and enhancer activities of SV40 variants isolated from patients with neurological diseases. Virus Res 19: 163-172.
32. Martini F, Iaccheri L, Lazzarin L, Carinci P, Corallini A, Gerosa M, Iuzzolino P, Barbanti-Brodano G, Tognon M (1996). SV40 region and large T antigen in human brain tumors, peripheral blood cells, and sperm fluids from healthy individuals. Cancer Res 56: 4820-4825.
33. Meinke W, Goldstein DA, Smith RA (1979). Simian virus 40-related DNA sequences in a human brain tumor. Neurology 29: 1590-1594.
34. Melnick JL, Stinebaugh S (1962). Excretion of vacuolating SV-40 virus (papova virus group) after ingestion as a contaminant of oral poliovaccine. Proc Soc Exp Biol Med 109: 965-968.
35. Pepper C, Jasani B, Navabi H, Wynford-Thomas D, Gibbs AR (1996). Simian virus 40 large T antigen (SV40LTAg) primer specific DNA amplification in human pleural mesothelioma tissue. Thorax 51: 1074-1076.
36. Pipas JM (1985). Mutations near the carboxyl terminus of the simian virus 40 large tumor antigen alter viral host range. J Virol 54: 569-575.
37. Reddy VB, Thimmappaya B, Dhar R, Subramanian KN, Zain BS, Pan J, Ghosh PK, Celma ML, Weissman SM (1978). The genome of simian virus 40. Science 200: 494-502.
38. Salzman NP, Natarajan V, Selzer GB (1986). Transcription of SV40 and polyoma virus and its regulation. In: The Papovaviridae, Vol. 1: The Polyomaviruses. Salzman NP (ed). Plenum Press: New York, pp 27-98.
39. Scherneck S, Rudolph M, Geissler E, Vogel F, Lüibbe L, Wählte H, Nisch G, Weickmann F, Zimmermann W (1979). Isolation of a SV40-like papovavirus from a human glioblastoma. Int J Cancer 24: 523-531.
40. Shah KV (1996). Polyomaviruses. In: Fields Virology, 3rd ed. Fields BN et al (eds). Lippincott-Raven: Philadelphia, pp 2027-2043.
41. Shah KV, McCrumb FR Jr, Daniel RW, Ozer HL (1972). Serologic evidence for a simian-virus-40-like infection of man. J Natl Cancer Inst 48: 557-561.
42. Shah KV, Nathanson N (1976). Human exposure to SV40: review and comment. Am J Epidemiol 103: 1-12.
43. Shah KV, Ozer HL, Pond HS, Palma LD, Murphy GP (1971). SV40 neutralizing antibodies in sera of US residents without history of polio immunization. Nature 231: 448-449.
44. Soriano F, Shelburne CE, Gökcen M (1974). Simian virus 40 in a human cancer. Nature 249: 421-424.
45. Spence SL, Pipas JM (1994). Simian virus 40 large T antigen host range domain functions in virion assembly. J Virol 68: 4227-4240.
46. Stewart AR, Lednicky JA, Benzick US, Tevethia MJ, Butel JS (1996). Identification of a variable region at the carboxy terminus of SV40 large T-antigen. Virology 221: 355-361.
47. Stinebaugh S, Melnick JL (1962). Plaque formation by vacuolating virus. Virology 16: 348-349.
48. Sweet BH, Hilleman MR (1960). The vacuolating virus, S.V.40. Proc Soc Exp Biol Med 105: 420-427.
49. Tevethia SS, Butel JS (1973/74). Induction of common transplantation antigen by various isolates of papovavirus SV40 and by virus rescued from transformed cells. Intervirology 2: 200-205.
50. Tornow J, Polvino-Bodnar M, Santangelo G, Cole CN (1985). Two separable functional domains of simian virus 40 large T antigen: Carboxyl-terminal region of simian virus 40 large T antigen is required for efficient capsid protein synthesis. J Virol 53: 415-424.
51. Weiner LP, Herndon RM, Narayan O, Johnson RT, Shah K, Rubinstein LJ, Preziosi TJ, Conley FK (1972). Isolation of virus related to SV40 from patients with progressive multifocal leukoencephalopathy. N Engl J Med 286: 385-390.
52. Woloschak M, Yu A, Post KD (1995). Detection of polyomaviral DNA sequences in normal and adenomatous human pituitary tissues using the polymerase chain reaction. Cancer 76: 490-496.
53. Zimmermann W, Scherneck S, Geissler E (1983). Quantitative determination of papovavirus IgG antibodies in sera from cancer patients, labworkers and several groups of control persons by enzyme-linked immunosorbent assay (ELISA). Zbl Bakt Hyg I Abt Orig A 254: 187-196.